Christian brings more than 20 years of expertise in medical devices, where he navigated responsibilities in business development, commercial leadership, product management, market development, and strategy. Prior to joining Cognito, he was Senior Vice President and General Manager of Aetion’s Medical Device and Diagnostic Group. In this role, Howell was responsible for the commercialization of Aetion’s real-world evidence platform to the medical device and diagnostics industry. During his nearly 15 year tenure at Medtronic, Christian led Medtronic’s Value-Based Health Care Partnerships organization, as well as P&L responsibility for Medtronic’s Integrated Health Solutions program to improve delivery of care and patient experience with partner health systems.
Recognized as a forward-thinking industry leader in value-based healthcare, Howell has presented on payment system transformation and partnership strategies with healthcare professionals around the world. Howell is a former Officer in the United States Navy and holds a Bachelor of Science degree from Tulane University.
In this interview, Cognito Therapeutics CEO Christian Howell will discuss the company’s non-invasive approach to treating Alzheimer’s disease using 40 Hz gamma sensory stimulation delivered through synchronized light and sound. The therapy is designed to evoke coordinated neural activity across brain networks and potentially slow disease progression. Howell will discuss Cognito’s clinical study, the foundational IP behindgamma sensory stimulation, and how emerging research points to broader neurological applications. He’ll also explain how the company is using AI to analyzescientific and clinical signals, strengthen its evidence strategy, and scale efficiently while pursuing one of medicine’s largest unmet needs.